NM joins four other states in suit against generic drug-makers
The Associated Press
July 17, 2017 11:06 AM
ALBUQUERQUE, N.M. – The Attorney General's office announced Monday that New Mexico has joined with four other states in filing a lawsuit in federal court against six drug manufacturers.
The suit alleges that the companies entered into illegal conspiracies in order to unreasonably restrain trade, artificially inflate and manipulate prices and reduce competition in the United States for two generic drugs.
A statement from the Attorney General's office released Monday regarding the suit lists the defendants as Heritage Pharmaceuticals, Inc., Aurobindo Pharma USA, Inc., Citron Pharma, LLC, Mayne Pharma (USA), Inc., Mylan Pharmaceuticals, Inc. and Teva Pharmaceuticals USA, Inc.
"I will continue to hold big out-of-state corporations accountable when then they rip off New Mexico consumers, and when companies put profits over patients, they will face the full extent of New Mexico law," Attorney General Hector Balderas said in the statement. "All New Mexico children, families and seniors deserve affordable access to the lifesaving medications that they rely on every day."
According to the statement,
The investigation -- which is still ongoing as to a number of additional generic drugs, generic drug companies and key executives -- uncovered evidence of a well-coordinated and long-running conspiracy to fix prices and allocate markets for doxycycline hyclate delayed release, an antibiotic, and glyburide, an oral diabetes medication.
The complaint alleges that the defendants routinely coordinated their schemes through direct interaction with their competitors at industry trade shows, customer conferences and other events, as well as through direct email, phone and text message communications. …
The suit further alleges that the drug companies knew that their conduct was illegal and made efforts to avoid communicating with each other in writing or, in some instances, to delete written communications after becoming aware of the investigation.
The lawsuit was filed under seal in U.S. District Court, according to the statement. Portions of the complaint are redacted in order to avoid compromising the ongoing investigation.
The Associated Press
Updated: July 17, 2017 11:06 AM
Created: July 17, 2017 10:58 AM
Copyright 2017 KOB-TV LLC, a Hubbard Broadcasting Company. All rights reserved